KC7F2 is a potent hypoxia inducible factor-1 (HIF-1) pathway inhibitor with an IC50 of 20 µM in LN229-HRE-AP cells, and with potential as a cancer therapy agent[1].
Molecular Weight:
570.38
Purity:
99.64
CAS Number:
[927822-86-4]
Formula:
C16H16Cl4N2O4S4
Target:
HIF/HIF Prolyl-Hydroxylase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted